Verus Capital Partners LLC Sells 200 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Verus Capital Partners LLC decreased its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 30.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 450 shares of the biotechnology company’s stock after selling 200 shares during the period. Verus Capital Partners LLC’s holdings in Axon Enterprise were worth $267,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in AXON. Prestige Wealth Management Group LLC increased its position in Axon Enterprise by 115.8% during the 3rd quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock worth $33,000 after buying an additional 44 shares during the period. New Wave Wealth Advisors LLC acquired a new stake in shares of Axon Enterprise during the 4th quarter worth $40,000. Brooklyn Investment Group acquired a new stake in shares of Axon Enterprise during the 3rd quarter worth $41,000. Y.D. More Investments Ltd acquired a new stake in shares of Axon Enterprise during the 4th quarter worth $45,000. Finally, Planning Capital Management Corp grew its holdings in shares of Axon Enterprise by 83.3% during the 3rd quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock worth $48,000 after purchasing an additional 55 shares in the last quarter. Institutional investors own 79.08% of the company’s stock.

Insider Activity

In other news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm’s stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the completion of the transaction, the director now directly owns 6,929 shares in the company, valued at $4,185,601.03. This trade represents a 6.10 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Jeffrey C. Kunins sold 1,035 shares of the firm’s stock in a transaction dated Monday, December 23rd. The stock was sold at an average price of $624.47, for a total value of $646,326.45. Following the transaction, the insider now owns 124,243 shares of the company’s stock, valued at $77,586,026.21. This trade represents a 0.83 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 8,711 shares of company stock valued at $5,631,561. 6.10% of the stock is currently owned by corporate insiders.

Axon Enterprise Stock Performance

Shares of AXON stock opened at $528.45 on Friday. The business’s 50-day moving average price is $609.55 and its 200-day moving average price is $524.28. Axon Enterprise, Inc. has a 12 month low of $273.52 and a 12 month high of $715.99. The firm has a market capitalization of $40.30 billion, a price-to-earnings ratio of 136.55, a PEG ratio of 5.17 and a beta of 1.05. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32.

Analysts Set New Price Targets

Several research firms have recently issued reports on AXON. JMP Securities reissued an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 4th. Robert W. Baird increased their target price on Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. Morgan Stanley raised Axon Enterprise from an “equal weight” rating to an “overweight” rating and increased their target price for the stock from $500.00 to $700.00 in a report on Tuesday, December 3rd. Northcoast Research lowered Axon Enterprise from a “buy” rating to a “neutral” rating in a report on Wednesday, February 19th. Finally, The Goldman Sachs Group increased their target price on Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a report on Monday, January 27th. Three analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $587.38.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.